Mycophenolate mofetil in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a prospective pharmacokinetics and clinical study
Version of Record online: 9 APR 2014
© 2013 British Society for Immunology
Clinical & Experimental Immunology
Volume 176, Issue 2, pages 172–179, May 2014
How to Cite
Chaigne, B., Gatault, P., Darrouzain, F., Barbet, C., Degenne, D., François, M., Szymanski, P., Rabot, N., Golea, G., Diot, E., Maillot, F., Lebranchu, Y., Nivet, H., Paintaud, G., Halimi, J.-M., Guillevin, L. and Büchler, M. (2014), Mycophenolate mofetil in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a prospective pharmacokinetics and clinical study. Clinical & Experimental Immunology, 176: 172–179. doi: 10.1111/cei.12246
- Issue online: 9 APR 2014
- Version of Record online: 9 APR 2014
- Accepted manuscript online: 5 DEC 2013 03:28AM EST
- Manuscript Accepted: 29 NOV 2013
Table S1. Correlation tests between patient characteristics and mycophenolic acid (MPA) pharmacokinetics [area under the curve (AUC)0–12].
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.